文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
E. Thompson
发表
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
S. Corti, M. Pane, E. Mercuri, 2021, The Lancet Neurology.